2 transcripts
ALKS
Earnings call transcript
NASDAQ
2024 Q2
24 Jul 24
environment. But the targets that Wall Street has bid up significantly are not going to be targets for us. But with our specialized commercial
ALKS
Earnings call transcript
NASDAQ
2023 Q4
15 Feb 24
biological rationale, challenging molecular design, a clear clinical pathway with early proof of concept, and importantly, in this intense payer environment
- Prev
- 1
- Next